Algernon Pharmaceuticals (TSE:AGN) has released an update.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Algernon Pharmaceuticals has extended the expiration date of nearly 4.75 million outstanding warrants by six months, now set to expire on May 5, 2025. This decision, which affects a significant portion held by company insiders, is subject to Canadian Securities Exchange approval but has already been granted certain exemptions.
For further insights into TSE:AGN stock, check out TipRanks’ Stock Analysis page.

